Sue Thomas explains how Wilmington Healthcare’s unique behavioural methodology is helping to define best practice pathways for patients with chronic kidney disease (CKD) during the pandemic
Sue Thomas explains how Wilmington Healthcare’s unique behavioural methodology is helping to define best practice pathways for patients with chronic kidney disease (CKD) during the pandemic
Steve How explains how Wilmington Healthcare’s unique behavioural methodology is being used to map patient journeys across the integrated care landscape
Life science companies were challenged by the sudden shift in ways of working as the COVID-19 pandemic began. But in moving critical work and even some large-scale events to virtual platforms, pharmaceutical teams learned valuable lessons and embraced new technologies that will become part of their long-term strategy.
The COVID-19 pandemic has brought into question how we approach care across multiple disease areas in the future. But what does this mean in cancer? Hear from Bristol Myers Squibb’s (BMS) Executive Medical Director, Hubert Bland, who believes that in order to advance in cancer care, we must learn from the COVID-19 response and adopt a collaborative approach across the healthcare industry.
To deliver high standards of support to healthcare professionals we have to be both digitally-savvy and relationship-smart
Dr Jason Raw outlines key findings from the SYNPASES trial, which explored the tolerability of safinamide used as an adjunct therapy in patients with Parkinson’s disease
The global COVID pandemic has highlighted the need for expert leadership in global healthcare. Oxford University is rising to the challenge, pulling together specialists from business and medical departments to launch an MSc in Global Healthcare Leadership
Ipsen Pharmaceuticals’ Global Digital Health Partnerships Lead, Dr Myles Furnace, discusses the company’s new partnership with digital health specialists Mendelian, which aims to improve the speed of diagnosis of rare diseases
ICON’s Michael Pellegrino outlines research looking at patient involvement in journal review processes
Imaginatively designed content combined with patient insights delivers campaigns that inspire behaviour change
Syneos Health’s Ewan Cutherbertson on lessons for biopharma marketers during COVID-19
The Royal Society of Chemistry has announced that its near 180-year old archive of research insights has been made available for Text and Data Mining projects, but why is this important?
Keeping the spirit of connection alive through the Have a Chat campaign
Consultations in a virtual world
The art of active listening